Monoclonal Antibodies (mAbs)
Recently, the Indian Council of Medical Research (ICMR) invited Expressions of Interest for developing and producing monoclonal antibodies (mAbs) as a countermeasure against Nipah virus, which continues to trigger repeated outbreaks in India.
- “Monoclonal antibodies” refers to lab-engineered antibodies that are designed to mimic natural immune antibodies by specifically recognising and neutralising a particular pathogen or antigen.
- It means that a single, identical antibody type is produced in large quantities to target one specific protein on a virus, offering precise and powerful protection or treatment.
- ICMR stressed that due to the absence of licensed vaccines and the high fatality rate of Nipah virus, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Ocean Thermal Energy Conversion (OTEC) Project in Lakshadweep
- 2 India Establishes Pilot Plant for Rare Earth Magnets at ARCI
- 3 NavIC Satellite IRNSS-1F Loses Atomic Clock
- 4 India Tests Indigenous Floating LiDAR Buoy System
- 5 DRDO Tests Indigenous Air Droppable Container ADC-150
- 6 INS Anjadip Commissioned
- 7 Indian Army Expands Pinaka Rocket Artillery Regiments
- 8 Minor Planet Centre Announces Discovery of 15 New Moons
- 9 ISRO Tests Upgraded CE20 Cryogenic Engine for LVM3
- 10 Scientists Detect Magnetic Waves Deep Inside the Sun
